Oral ibandronate reduces activation frequency to healthy premenopausal levels in women with postmenopausal osteoporosis

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S155 / S156
页数：2
相关论文
共 50 条
  • [31] Adiponectin and negative mood in healthy premenopausal and postmenopausal women
    Adam, Tanja
    Schamarek, Imke
    Springer, Elizabeth A.
    Havel, Peter J.
    Epel, Elissa E.
    HORMONES AND BEHAVIOR, 2010, 58 (05) : 699 - 704
  • [32] PREVALENCE OF KYPHOSIS IN A HEALTHY SAMPLE OF PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
    CUTLER, WB
    FRIEDMANN, E
    GENOVESESTONE, E
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1993, 72 (04) : 219 - 225
  • [33] Raloxifene reduces fractures in postmenopausal women with osteoporosis
    Reginster, Jean-Yves
    Devogelaer, Jean-Pierre
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (443) : 48 - 54
  • [34] Women prefer once-monthly oral ibandronate to weekly oral alendronate as postmenopausal osteoporosis treatment: Results of BALTO II
    Barrett-Connor, E.
    Bourgeois, P.
    Devas, V
    Masanauskaite, D.
    Minne, H.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S234 - S235
  • [35] Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)
    Hadji, Peyman
    Minne, Helmut
    Pfeifer, Michael
    Bourgeois, Pierre
    Fardellone, Patrice
    Licata, Angelo
    Devas, Vipul
    Masanauskaite, Daiva
    Barrett-Connor, Elizabeth
    JOINT BONE SPINE, 2008, 75 (03) : 303 - 310
  • [36] Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis
    Ravn, P
    Neugebauer, G
    Christiansen, C
    BONE, 2002, 30 (01) : 320 - 324
  • [37] Oral weekly ibandronate prevents bone loss in postmenopausal women
    Tankó, LB
    Felsenberg, D
    Czerwinski, E
    Burdeska, A
    Jonkanski, I
    Hughes, C
    Christiansen, C
    JOURNAL OF INTERNAL MEDICINE, 2003, 254 (02) : 159 - 167
  • [38] Once-Monthly Oral Ibandronate in Postmenopausal Osteoporosis: Translation and Updated Review
    Rossini, Maurizio
    Viapiana, Ombretta
    Gatti, Davide
    Adami, Silvano
    CLINICAL THERAPEUTICS, 2009, 31 (07) : 1497 - 1510
  • [39] Daily and intermittent oral ibandronate: An evaluation of bone histomorphometry in postmenopausal osteoporosis.
    Recker, RR
    Meunier, PJ
    Chesnut, CH
    Hughes, C
    Bonvoisin, B
    Weinstein, RS
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S448 - S449
  • [40] Ibandronate: A comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis
    Riis, BJ
    Ise, J
    Von Stein, T
    Bagger, Y
    Christiansen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) : 1871 - 1878
12345